Cardinal Health Inc. saw a 56% drop in its fiscal second-quarter earnings, and lowered its overall earnings outlook for 2008, citing several issues affecting its pharmaceutical unit, including an expectation of price increases for branded drugs and dipping prices in the generic-drugs market. Following the end of the quarter, Cardinal Health wrapped an early renewal of a multiyear pharmaceuticals distribution agreement with Walgreens Co.

Full Story:

Related Summaries